These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4023730)

  • 21. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM; Coceani F
    Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Prostaglandin E1 for interrupted aortic arch in the neonate.
    Radford DJ; Bloom KR; Coceani F; Fariello R; Olley PM
    Lancet; 1976 Jul; 2(7976):95. PubMed ID: 59171
    [No Abstract]   [Full Text] [Related]  

  • 28. Resolution of prostaglandin-induced cortical hyperostosis in an infant.
    Alpert BS; Jureidini SB; Vanderzalm T
    South Med J; 1984 Aug; 77(8):1039-40. PubMed ID: 6540475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of prostaglandin-E1 on patients with pulmonary atresia (author's transl)].
    Usui K; Kuroda N; Matsukawa S; Sato M; Fukuda M; Ishizawa E
    Kyobu Geka; 1978 Dec; 31(12):908-11. PubMed ID: 723053
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.
    Thanopoulos BD; Andreou A; Frimas C
    Eur J Pediatr; 1987 May; 146(3):279-82. PubMed ID: 3474149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral prostaglandin E2 in ductus-dependent pulmonary circulation.
    Silove ED; Coe JY; Shiu MF; Brunt JD; Page AJ; Singh SP; Mitchell MD
    Circulation; 1981 Mar; 63(3):682-8. PubMed ID: 7460252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged prostaglandin E1 infusion: histologic effects on the patent ductus arteriosus.
    Cole RB; Abman S; Aziz KU; Bharati S; Lev M
    Pediatrics; 1981 Jun; 67(6):816-9. PubMed ID: 7232045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prostaglandin E1 therapy in congenital heart defects.
    Teixeira OH; Carpenter B; MacMurray SB; Vlad P
    J Am Coll Cardiol; 1984 Mar; 3(3):838-43. PubMed ID: 6537955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
    Lillquist K
    Ugeskr Laeger; 1979 Jul; 141(28):1915-6. PubMed ID: 473414
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged prostaglandin E1 infusion in an infant with cyanotic congenital heart disease.
    Lewis AB; Lurie PR
    Pediatrics; 1978 Apr; 61(4):534-6. PubMed ID: 662477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic maintenance of the ductus arteriosus.
    Freed MD
    Conn Med; 1982 Mar; 46(3):131-4. PubMed ID: 7075183
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases.
    Calder AL; Kirker JA; Neutze JM; Starling MB
    Pediatr Cardiol; 1984; 5(2):85-92. PubMed ID: 6591146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular therapy in the newborn.
    Sandor GG
    Clin Invest Med; 1985; 8(4):360-7. PubMed ID: 3907921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy.
    Silver MM; Freedom RM; Silver MD; Olley PM
    Hum Pathol; 1981 Dec; 12(12):1123-36. PubMed ID: 7199511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.